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ARTICLE
Positive surface charge of GluN1 N-terminus
mediates the direct interaction with EphB2
and NMDAR mobility
Halley R. Washburn1,3, Nan L. Xia1,2,3, Wei Zhou 1,3, Yu-Ting Mao1 & Matthew B. Dalva 1*
Localization of the N-methyl-D-aspartate type glutamate receptor (NMDAR) to dendritic
spines is essential for excitatory synaptic transmission and plasticity. Rather than remaining
trapped at synaptic sites, NMDA receptors undergo constant cycling into and out of the
postsynaptic density. Receptor movement is constrained by protein-protein interactions with
both the intracellular and extracellular domains of the NMDAR. The role of extracellular
interactions on the mobility of the NMDAR is poorly understood. Here we demonstrate that
the positive surface charge of the hinge region of the N-terminal domain in the GluN1 subunit
of the NMDAR is required to maintain NMDARs at dendritic spine synapses and mediates
the direct extracellular interaction with a negatively charged phospho-tyrosine on the
receptor tyrosine kinase EphB2. Loss of the EphB-NMDAR interaction by either mutating
GluN1 or knocking down endogenous EphB2 increases NMDAR mobility. These ﬁndings
begin to deﬁne a mechanism for extracellular interactions mediated by charged domains.
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Synaptic function and synaptic plasticity rely on the preciselocalization of glutamate receptors within the postsynapticdensity of spine synapses1–3. N-methyl-D-aspartate recep-
tors (NMDARs) are one of the three major types of ionotropic
glutamate receptors and are essential for many types of plasticity4.
NMDARs are heterotetramers composed of homologous sub-
units: two GluN1 and two GluN2 (four subtypes, A–D) or GluN3
(two subtypes, A and B). The extracellular domains of the GluN2
subunits contain the glutamate-binding site while GluN1 subunits
bind co-agonist glycine and are essential for NMDAR function4.
The extracellular region of the GluN1 subunit consists of two
large domains, the ligand-binding domain (LBD), which contains
the glycine-binding site, and the N-terminal domain (NTD). The
clamshell-like structure of NMDAR subunit NTDs allosterically
regulates NMDAR channel function by binding to modulators,
such as zinc, polyamines, and ifenprodil5,6. While the molecules
that bind to the GluN2B NTD and the GluN1/GluN2B NTD
interface are well characterized7–10, binding partners for the
GluN1 NTD remain unknown.
Retention of the NMDAR in the postsynaptic density is essential
for synaptic plasticity. However, rather than remaining static at
synaptic sites, synaptic NMDARs are in a dynamic equilibrium
between diffusion-driven exchange with other membrane com-
partments and conﬁnement at synaptic sites by protein–protein
interactions11. Retention of NMDARs at synapses is regulated by
both intracellular scaffolding proteins, such as PSD-9512, and
extracellular interacting proteins, such as the EphB receptor tyr-
osine kinases (RTKs)13. While the impact of intracellular inter-
actions on NMDAR mobility are well understood14–16, the role of
extracellular interactions on the mobility of the NMDAR at
synaptic sites is less well deﬁned.
Ligand-dependent activation of EphB RTKs results in the
direct interaction between the extracellular domains of EphB2
and the NMDAR GluN1 subunit13. Expression of EphBs is
required for normal synaptic levels of NMDARs in the mature
brain17,18. Interaction with EphB2 results in increased NMDAR-
dependent calcium inﬂux, modulation of NMDAR channel
function, phosphorylation of the GluN2B subunit of the
NMDAR, and enhanced surface retention of the NMDAR13,17,19.
Moreover, defects in the EphB–NMDAR interaction are asso-
ciated with multiple diseases including anti-NMDAR encephalitis
and Alzheimer’s disease20,21. Binding of EphB2 to the NMDAR
requires phosphorylation of Y504, an extracellular tyrosine
(p*Tyr) residue in the ﬁbronectin type-III (FN3) domain of
EphB2. Phosphorylation of EphB2 Y504 is necessary and sufﬁ-
cient for the EphB–NMDAR interaction and a negative charge at
Y504 is required for the EphB–NMDAR interaction and synaptic
localization of the NMDAR19. However, the interaction site on
GluN1 and the mechanism responsible for the EphB–NMDAR
interaction are unknown.
Intracellular interactions between p*Tyr residues are often
mediated by SH2 domain binding. SH2 domains mediate
protein–protein interactions by recognizing speciﬁc p*Tyr resi-
dues within speciﬁc short linear amino acid sequences22. Among
a number of factors23,24, one key determinant for recognition is
the positive surface charge in regions of the SH2 domain that
coordinates the negative charge of the p*Tyr residue24,25. How-
ever, whether similar mechanisms might regulate interactions
between the extracellular domains of proteins is not known. The
recent discovery of mechanisms which mediate extracellular
phosphorylation19,26–30 and the requirement of a negatively
charged p*Tyr for the EphB2–NMDAR interaction suggest that
the interaction domain on the NMDAR responsible for the
EphB–NMDAR interaction might be positively charged.
Here we use a combined approach of modeling and site-
directed mutagenesis to deﬁne the region of the NMDAR that is
required for the extracellular interaction with EphB2. We deﬁne
an area within the hinge region of the GluN1 NTD as necessary
for the EphB2–NMDAR interaction. Interestingly, the interac-
tion domain emerges from the tertiary structure of the
GluN1 subunit. Mutations in the hinge region that neutralize or
reverse the positive surface potential reduce or eliminate the
EphB2–NMDAR interaction. Disrupting the ability of GluN1 to
interact with EphB2 increases the mobility of the NMDAR at
dendritic spine synapses. These data deﬁne a charge-dependent
mechanism mediating stabilization of the NMDAR in dendritic
spines and suggest a non-canonical mechanism as a functional
role for extracellular phosphorylation that may mediate
protein–protein interactions.
Results
EphB2 interacts with NMDARs at synapses. EphB2 and the
NMDAR interact in brain lysates, at synapses in cultured neurons,
and directly in vitro17,19. To understand the mechanism underlying
the EphB–NMDAR interaction, we tested whether endogenous
EphB2 and NMDARs interact at synapses using synaptosomes
isolated from mouse brain (Supplementary Fig. 1a)19,31,32. Synap-
tosomes provide a system in which epitopes for antibody binding
are accessible while maintaining much of the endogenous synaptic
organization32,33. Immunostaining of synaptosomes for endogen-
ous EphB2 and GluN1 reveals that these proteins are found at
77.6% (EphB2) and 51.4% (GluN1) of vGlut1-positive sites (Fig. 1a,
b, Supplementary Fig. 1b). Approximately 30% of vGlut1-positive
synaptosomes colocalized with both EphB2 and GluN1 (29 ± 3.7%;
Fig. 1a, b, Supplementary Fig. 1b). To test whether these proteins
might be interacting, we conducted immunocytochemistry (ICC)
for vGlut1-positive presynaptic sites followed by rolling-circle
ampliﬁcation proximity ligation assays (PLAs) in synaptosomes
with antibodies against the extracellular domains of GluN1 (anti-
GluN1) and EphB2 (anti-EphB2; PLA schematic; Fig. 1c, Supple-
mentary Fig. 1c)34. Consistent with our immunostaining data,
~20% of vGlut1-positive sites showed endogenous EphB2–GluN1
PLA signal (19.8 ± 2.7%; Fig. 1d, Supplementary Fig. 1c). These
ﬁndings suggest that EphB2 and GluN1 interact at most synaptic
sites where both proteins colocalize.
The NTD of GluN1 is necessary for the EphB–NMDAR
interaction. NMDA receptor encephalitis is a rare autoimmune
disease characterized by auto-antibody-binding to the NMDAR
NTD35. Patient-derived anti-NMDAR antibodies disrupt the
EphB–NMDAR interaction, decreasing surface expression and
increasing NMDAR mobility20. Conversely, treatment of neurons
with the EphB ligand, ephrin-B2, induces EphB to compete with
patient auto-antibodies for NMDAR binding, increasing the
EphB–NMDAR interaction and blocking the effects of the
patient-derived antibodies20,36. These data suggest that the GluN1
NTD hinge region might be important for the EphB–NMDAR
interaction35. Therefore, we sought regions of the GluN1 extra-
cellular domain near the NTD hinge with positive surface
potential that might interact with the negatively charged EphB2
p*Y504 site.
To determine the surface potential within the NTD of GluN1
(Fig. 2a), we used the crystal structure of the GluN1 NTD (PDB:
4PE5; Fig. 2b) and the adaptive Poisson–Boltzmann solver
(APBS) to visualize the electrostatic surface potential37. The
hinge region is positively charged on the exposed surface of the
protein, facing away from the channel and away from the
GluN2B subunit (Fig. 2a, e, positive= blue, negative= red,
neutral=white). In contrast, the homologous region of GluN2B
(PDB: 4PE5) is negatively charged (Supplementary Fig. 2a). The
region responsible for the positive surface potential within the
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GluN1 NTD is composed of six amino acids (I272, N273, T335,
G336, R337, and N350) (Fig. 2c, d). Interestingly, unlike
canonical SH2 domain tyrosine-binding domains24,38, the
residues generating the positively charged region in the NTD
are not in β-sheets or a linear sequence, but instead are in
unstructured loops in spatial proximity to one another.
To begin to determine whether the positive surface charge of
the NTD hinge region might play a role in the EphB–NMDAR
interaction, all six amino acids forming the positive region of the
NTD hinge were mutated (Sextuple GluN1 mutant: I272A/
N273A/T335A/G336A/R337A/N350Q). APBS predicts that the
Sextuple mutant will result in a negative surface potential
compared to wild-type (WT) GluN1 (Fig. 2f, right). One of the
amino acids identiﬁed, N350, is an N-linked glycosylation site39.
Consistent with these ﬁndings, the GluN1 Sextuple mutant with
N350Q migrates on a western blot with a shift in apparent
molecular weight consistent with a loss of glycosylation
(Supplementary Fig. 2b). Therefore, although glycosylation of
N350 does not appear to regulate surface localization of the
NMDAR39, we also generated a Quintuple GluN1 mutant that
lacks the mutation at N350 (Quintuple GluN1 mutant: I272A/
N273A/T335A/G336A/R337A). APBS indicates that the Quintu-
ple mutant also results in a signiﬁcant change in the surface
potential in the hinge region (Fig. 2f).
To test whether the GluN1 hinge region charge mutants
disrupt the EphB2–NMDAR interaction, we performed PLA on
unpermeablized HEK293T cells expressing EGFP, FLAG-tagged
EphB2 (FLAG-EphB2), GluN2B, and either WT, Quintuple, or
Sextuple mutant Myc-tagged GluN1 (Myc-GluN1). The epitope
tags on both GluN1 and EphB2 were placed in the extracellular
domains after the signal peptide. Control experiments validated
that PLA puncta are speciﬁc to the presence of both proteins and
both antibodies (Supplementary Fig. 1d, e), showed that these
proteins were on the cell surface (Supplementary Fig. 2c, d), and
that GluN1 mutants expressed at similar or slightly higher levels
compared to WT GluN1 in HEK293T cells (Supplementary
Fig. 2e–g). These data suggest that any reductions in the
EphB2–NMDAR interaction detected are not due to decreases
in protein expression or failure of the GluN1 subunits to reach
the cell surface.
To determine whether the surface charge of the GluN1 NTD
hinge region is important for the EphB–NMDAR interaction,
transfected HEK293T cells were ﬁxed and PLA was performed for
the extracellular domains of GluN1 (anti-Myc) and EphB2 (anti-
EphB2)34. The interaction between GluN1 and EphB2 was
determined by quantifying the number of PLA puncta in
EGFP-positive cells40,41. The EphB2–NMDAR interaction was
signiﬁcantly reduced in both Quintuple and Sextuple mutant
GluN1-transfected conditions compared to WT (Fig. 2g, h, ***p <
0.005, ANOVA). These data suggest that a positive surface
potential in the hinge region of the GluN1 NTD is necessary for
the EphB–NMDAR interaction.
We next asked whether changing the surface potential of the
GluN1 NTD hinge region might disrupt the EphB2–NMDAR
interaction in neurons. Experiments in primary cortical rat
neurons were conducted using a molecular replacement strategy
where endogenous GluN1 was knocked out using transfectable
CRISPR reagents (Supplementary Fig. 3)42,43. Neurons were
transfected with WT, Quintuple mutant, or Sextuple mutant
EGFP–GluN1, as well as GluN2B and mCherry at day in vitro 3
(DIV3). Both mutant and WT GluN1 proteins were localized to
the neuronal surface (Supplementary Fig. 4a, b) and all mutant
receptor-channels ﬂuxed calcium in response to glutamate appli-
cation with kinetics similar to wild-type at DIV8-10 (Supple-
mentary Fig. 5)44.
Next, we asked whether mutations to the hinge region of
the GluN1 NTD might disrupt the EphB2–NMDAR interaction.
To test this, we used a previously described assay in which
DIV6-9 neurons are treated with soluble activated ephrin-B2 for
45 min to induce the surface interaction between EphB2 and the
NMDAR13,17,19. The colocalization of transfected EGFP–GluN1
and endogenous EphB2 was quantiﬁed using custom macros19,45.
Ephrin-B2 activation resulted in clustering of EphB2 in all
conditions (Fig. 3a, b). GluN1 and EphB2 puncta density were the
same across the three ephrin-treated groups (Fig. 3b, p= 0.1006;
Fig. 3c, p= 0.4199; ANOVA), suggesting that effects on
colocalization are not due to changes in EphB2 or NMDAR
expression or puncta number. Ephrin treatment of WT GluN1-
transfected neurons resulted in increased EphB2–GluN1 co-
clustering compared to control (Fig. 3a, d, ****p < 0.0001,
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Fig. 1 GluN1 interacts with EphB2 at synapses. a Representative images of synaptosomes immunostained for GluN1 in green, EphB2 in red, and vGlut1 in
cyan. Far right panel shows merged image. Scale bar= 1.5 µm. b Quantiﬁcation of the percentage of vGlut1+ synaptosomes that colocalize with either
EphB2 only, GluN1 only, or both EphB2 and GluN1 (green dots represent n= 612 synaptosomes, ﬁve ﬁelds). c Schematic of proximity ligation assay shows
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secondary probes bind. Representative images of synaptosomes immunostained for vGlut1 in cyan (middle panel). PLA between EphB2 and GluN1 is shown
in magenta (left panel). Right panel shows merged image. Scale bar= 1.5 µm. d Quantiﬁcation of the percentage of vGlut1+ synaptosomes that colocalize
with PLA puncta (PLA+ ICC). The control condition (PLA Ctrl) was performed without EphB2 primary antibody (****p < 0.0001, unpaired t-test; green
dots represent PLA Ctrl n= 569, 6 ﬁelds; PLA+ ICC n= 421 synaptosomes, 11 ﬁelds).
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ANOVA). Both the Quintuple and Sextuple GluN1 hinge
mutants were signiﬁcantly less well colocalized with EphB2
than WT GluN1 after ephrin treatment (Fig. 3a, d, ****p < 0.0001,
***p < 0.005; ANOVA). Together, these data suggest that the
positive surface charge of the hinge region of the NTD is
necessary for the EphB–NMDAR interaction.
Surface potential of the GluN1 hinge mediates NMDAR
mobility. The EphB–NMDAR interaction regulates the stability
of the NMDAR at synaptic sites in mature neurons17. Mice
lacking EphB1–3 have reduced levels of NMDARs at synaptic
sites and knockdown of EphB2 in mature neurons drives
GluN2B-containing NMDARs from synapses17. Consistent with
the model that these events depend on the EphB–NMDAR
interaction, treatment of neurons with patient-derived anti-
NMDAR antibodies that block the EphB–NMDAR interaction
increases the diffusion of NMDARs out of synapses20. These data
suggest that the EphB–NMDAR interaction is important for the
synaptic stability of the NMDAR.
We next asked whether decreasing the positive surface
potential of the hinge region of the NTD, which reduces
the EphB–NMDAR interaction, might increase mobility of the
NMDAR at synaptic sites. We focused on older neurons, as
the EphB–NMDAR interaction regulates the localization of the
NMDAR in mature neurons17,46. Neurons were transfected with
WT, Quintuple, or Sextuple EGFP–GluN1, GluN2B, mCherry,
and CRISPR constructs to knockout endogenous GluN142 at
DIV14. The mobility of the NMDAR in mature neurons
(DIV21–23) was measured using ﬂuorescence recovery after
photobleaching (FRAP) in mCherry-positive EGFP–GluN1-
expressing neurons. The relative intensity of the diffuse and
clustered EGFP–GluN1 signal was not signiﬁcantly different
across groups, suggesting that overall localization of mutants was
similar to WT (Supplementary Fig. 4c, d). Over 80% of GluN1
puncta localized to the cell surface and only EGFP–GluN1 puncta
in dendritic spines were selected for photobleaching to ensure our
results were not reﬂective of the intracellular pool of receptors
(Supplementary Fig. 4a, b, Fig. 3a). FRAP of EGFP–GluN1 puncta
was determined by bleaching and then monitoring recovery of a
a
e
b c
g
*** ***
f
d
GluN2B
h
NTD
LBD
TMD
CTD
WT
PL
A
+
–
+
–
Quintuple
M
er
ge
Sextuple
PDB:
4PE5
90°
4
3
2
N
or
m
al
iz
ed
 P
LA
 p
un
ct
a
1
0
WT
Qu
intu
ple
Se
xtu
ple
GluN1
N350I272
N273
T335
R337
G336
Fig. 2 GluN1 hinge mutants disrupt the EphB2–GluN1 interaction in HEK293T cells. a A model of domain organization of the GluN1 and the GluN2B
subunits of the NMDA receptor. The red box indicates the N-terminal domain (NTD) of GluN1. b The crystal structure of the NTD of GluN1 (PDB: 4PE5).
The red box indicates the hinge region within the NTD with speciﬁc amino acids highlighted in red. c The structure of the GluN1 NTD hinge region
represented in cartoon form with the location of six amino acids highlighted in red (I272, N273, T335, G336, R337, N350). d The surface representation of
the structure of the GluN1 NTD hinge region with the location of the six amino acids in c highlighted in red. e Charge map of the GluN1 NTD hinge region.
The charge map was generated using the adaptive Poisson–Boltzmann solver (APBS) plugin in PyMOL. f Charge maps of GluN1 NTD hinge region mutants
(WT, Quintuple, Sextuple). Yellow outline indicates the location of the six key hinge region amino acids in WT GluN1. g Representative images of the PLA
assay results in HEK293T cells. HEK293T cells were transfected with either WT Myc-GluN1, Quintuple mutant Myc-GluN1 (I272A/N273A/T335A/
G336A/R337A), or Sextuple mutant Myc-GluN1 (I272A/N273A/T335A/G336A/R337A/350Q), and GluN2B, FLAG-tagged-EphB2, and EGFP. The upper
panels show PLA signal alone. The lower panels are the merged images with EGFP in green and PLA signal in magenta. Scale bar= 10 µm. h Quantiﬁcation
of the effects of GluN1 mutants on PLA puncta number. PLA puncta number are quantiﬁed by counting the number of puncta per 100 µm2 in EGFP+ cells
and normalizing to the WT condition (***p < 0.005, ANOVA; green dots represent n= 30 cells for each condition).
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14345-6
4 NATURE COMMUNICATIONS |          (2020) 11:570 | https://doi.org/10.1038/s41467-020-14345-6 | www.nature.com/naturecommunications
puncta for 30 min, imaging once every 30 s. Both GluN1 hinge
mutants recovered at a signiﬁcantly higher rate than the WT
(Fig. 4b, p < 0.001, Kolmogorov–Smirnov (KS) nonparametric
test) and to a higher degree than WT EGFP–GluN1 (Fig. 4b inset,
*p < 0.05, ANOVA). These data indicate that the mutant
NMDARs with less positive surface charge have a larger mobile
fraction compared to WT, likely resulting from the disruption of
the interaction between EphB and the NMDAR.
Impact of glycosylation of GluN1 N350 in HEK293T cells.
Within the positive surface potential of the NTD hinge region,
N350 is an N-linked glycosylation site39,47. To discern whether
the glycosylation or the charge of N350 is more important for
GluN1’s interaction with EphB2, we made two mutants: GluN1
N350Q and GluN1 N350A. Both mutations to N350 likely result
in a loss of glycosylation as seen by the shift in western blot
migration (Supplementary Fig. 6a), however APBS predicts that
the N350Q mutation will also drive the surface potential of the
NTD hinge region negative, while the N350A mutation will
result in little detectable change in surface potential (Supple-
mentary Fig. 6e). To test whether N350 is necessary for the
EphB–NMDAR interaction, we conducted PLA in HEK293T cells
transfected with FLAG-EphB2, EGFP, and either WT, N350Q
or N350A Myc-GluN1. Mutants expressed at similar or slightly
higher levels compared to WT GluN1 in HEK293T cells
(Supplementary Fig. 6b–d). GluN1 N350Q-transfected cells, but
not N350A, had signiﬁcantly fewer PLA puncta than WT GluN1-
transfected cells (Supplementary Fig. 6f, g, WT vs. N350Q,
***p= 0.0018; WT vs. N350A, p= 0.1055; N350A vs. N350Q,
p= 0.3078; ANOVA). These data suggest that the ability of the
NMDAR to interact with EphB2 is independent of glycosylation
state in the hinge region.
The amino acids required for the EphB2–GluN1 interaction.
To begin to determine which amino acids in the NTD hinge
region might mediate the EphB–NMDAR interaction, we gen-
erated six individual point mutants to each of the amino acids
that form the area of positive surface charge (I272A, N273A,
T335A, G336A, R337A, R337D). These mutants were chosen
because they affect surface charge and not the glycosylation
state of the GluN1 subunit. Each of these mutants trafﬁcked
to the cell surface at similar levels and ran as expected on western
blots (Supplementary Fig. 7a–d, 7c, p= 0.0613; 7d, p= 0.1349;
ANOVA). APBS models showed that mutations to N273 and
R337 had the largest impact on the surface potential (N273A,
R337A, and R337D) (Fig. 5a). If the positive surface charge of the
GluN1 NTD hinge region mediates the EphB–NMDAR interac-
tion, then the three GluN1 mutants that affect surface potential
the most should disrupt the EphB2–NMDAR interaction. To test
whether those charge mutants affect the interaction, PLA was
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performed on HEK293T cells transfected with each of the
GluN1 single mutants (I272A, N273A, T335A, G336A, R337A,
R337D), together with GluN2B, EphB2, and EGFP (Fig. 5b).
Consistent with the charge-based model for the EphB–NMDAR
interaction, the GluN1 mutants with the largest apparent effect
on surface charge, N273A, R337A, and R337D, had signiﬁcantly
fewer PLA puncta per cell than WT (Fig. 5c, ****p < 0.0001,
ANOVA). Mutations that did not alter the surface charge did not
impact the number of PLA puncta (Fig. 5c, I272A vs. WT, p=
1.000; T335A vs. WT, p= 0.999; G336A vs. WT, p= 0.1489;
ANOVA). Similarly, Myc-GluN1 N273 and R337 mutants co-
immunoprecipitated FLAG-EphB2 less well than WT Myc-
GluN1 (Supplementary Fig. 8). These data suggest that a posi-
tive surface potential in the NTD hinge region is necessary for the
EphB–NMDAR interaction.
To test whether positive surface potential is important for the
EphB–NMDAR interaction, we asked whether combining point
mutants that affect the surface charge within the putative
interaction domain might alter the EphB2–NMDAR interaction.
To test this, we generated GluN1 double point mutants that APBS
prediction indicated will have a negative surface potential
(N273A/R337A and N273A/R337D; Fig. 5d). Both mutants
express at similar levels, are found on the cell surface at similar
levels, and migrate on western blots as expected (Supplementary
Fig. 7e–h; 7g, p= 0.1921; 7h, p= 0.4097; ANOVA). As expected,
PLA reveals that both double point mutants (N273A/R337A and
N273A/R337D) interact signiﬁcantly less well with FLAG-EphB2
compared to WT GluN1 in HEK293T cells (Fig. 5e, f, ****p <
0.0001, ANOVA). These data suggest that the positive surface
charge generated by amino acids N273 and R337 of the NTD
hinge region of the NMDAR GluN1 subunit is required for the
EphB–NMDAR interaction.
Disruption of the EphB2–NMDAR interaction. Phosphoryla-
tion of EphB2 Y504 and a negative charge at Y504 are required
for interaction with the NMDAR19. To test how the charge of
Y504 affects the EphB2–NMDAR interaction, PLA was per-
formed on HEK293T cells transfected with EphB2 WT, EphB2
Y504E, or EphB2 Y504F, and WT Myc-GluN1, GluN2B, and
EGFP (Fig. 6a). As expected, cells transfected with the more
positively charged EphB2 phospho-null mutant (Y405F) had
signiﬁcantly fewer PLA puncta than both WT EphB2 and the
more negatively charged phosphomimetic (Y504E) EphB2
(Fig. 6b, ****p < 0.0001, ANOVA). To speciﬁcally test the role of a
negative charge at EphB2 Y504 in relation to the GluN1 charge
mutants, PLA was performed on HEK293T cells transfected with
EphB2 Y504E, GluN2B, EGFP and Myc-GluN1 WT or GluN1
point mutants (Fig. 6c, e). Consistent with the model that the
negative charge of phosphomimetic EphB2 Y504E interacts with
the positive potential of the GluN1 NTD hinge region, mutations
in GluN1 that result in larger negative shifts of surface potential
interact with EphB2 Y504E less well than those with smaller dif-
ferences (Fig. 6d, f, WT vs. N273A, *p < 0.05; WT vs. R337D,
***p < 0.005; WT vs. N273A/R337D, ****p < 0.0001; ANOVA).
Unfortunately, mutations of Y504 to a positively charged amino
acid failed to reach the cell surface. Together these results suggest
that the positively charged hinge region of GluN1 interacts with
the negatively charged phosphorylated Y504 of EphB2 and this
interaction is disrupted when GluN1 is mutated to become more
negatively charged.
Because the N273A/R337D GluN1 mutant appeared to have
the most negative surface potential and had the strongest effect
on the EphB2–NMDAR interaction (Fig. 5), we next asked
whether it might disrupt the EphB2–NMDAR interaction in
neurons. Surface staining showed that, following molecular
replacement of GluN1, mutant (I272A and N273A/R337D) and
WT GluN1 were localized to the neuron surface (Supplemen-
tary Fig. 9a, b). To test the effects of the mutants on the
EphB2–NMDAR interaction, molecular replacement was
conducted with WT EGFP–GluN1, I272A or N273A/R337D
GluN1 mutants. Neurons were co-tranfected with GluN2B
and mCherry. EphB clustering was induced with activated
ephrin-B213 and colocalization of endogenous EphB2 and
EGFP–GluN1 was determined19,45. Ephrin-B2 activation
resulted in clustering of EphB2 in all conditions (Fig. 7a, b).
GluN1 and EphB2 puncta density were the same across the
three ephrin-treated groups (Fig. 7b, c), suggesting that the
effects on colocalization were not due to changes in EphB2 or
NMDAR expression or puncta number. Ephrin treatment of
WT GluN1 and GluN1 I272A-transfected neurons resulted in
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increased EphB2–GluN1 co-clustering compared to control
(Fig. 7a, d, *p < 0.05, ANOVA). In contrast, the N273A/R337D
GluN1 charge mutant was signiﬁcantly less well colocalized
with EphB2 compared to WT GluN1 (Fig. 7a, d, *p < 0.05,
ANOVA). Together, these data suggest that the positive surface
charge provided by N273 and R337 is necessary for the
EphB–NMDAR interaction in neurons.
Impact on synaptic stability of the NMDAR. Disrupting the
EphB2–NMDAR interaction by mutating the hinge region of
GluN1 results in increased mobility of NMDARs found in den-
dritic spines. We next asked whether the GluN1 N273A/R337D
charge mutant is sufﬁcient to increase the mobility of the
NMDAR in dendritic spines. To test this, neurons were trans-
fected with either WT EGFP–GluN1, EGFP–GluN1 I272A, or
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EGFP–GluN1 N273A/R337D, and GluN2B, mCherry, and GluN1
CRISPR. No signiﬁcant differences were found between levels of
WT or mutant EGFP–GluN1 in the dendritic shaft (Supple-
mentary Fig. 9c, d), but there was a decrease in spine density in
N237A/R337D expressing neurons (Supplementary Fig. 9e, f).
EGFP–GluN1 mobility in dendritic spines was examined by
FRAP, and images of EGFP–GluN1 puncta were collected once
every 10 s for 15 min after bleaching. Fluorescence recovery of
both WT and I272A EGFP–GluN1 was indistinguishable (Fig. 8a,
b). In contrast, EGFP–GluN1 N273A/R337D recovered sig-
niﬁcantly more than WT (Fig. 8b, ****p < 0.0001, KS test; 15 min
time point, *p < 0.05, ANOVA). These results suggest converting
the surface charge in the hinge region of the GluN1 NTD
increases NMDAR mobility at spines.
To test whether the increased mobility of EGFP–GluN1
N273A/R337D is caused by disruption of the EphB2–NMDAR
interaction, we examined the impact of knocking down
endogenous EphB2 in neurons transfected with WT or
N273A/R337D EGFP–GluN1. If N273 and R337 are respon-
sible for the EphB–NMDAR interaction and the stability of the
NMDAR, then, following EphB2 knockdown, the WT but not
the EGFP–GluN1 N273A/R337D mutant should show
increased recovery after bleaching. To avoid potential con-
founds due to changes in synapse number, EphB2 was knocked
down at DIV14, when knockdown of EphB2 has no effect on
synapse density46. Consistent with this model, there was no
effect on spine density along the dendrite when EphB2 was
knocked down with a validated EphB2 shRNA construct17,46 at
DIV14 in neurons expressing EGFP–GluN1 WT, GluN2B,
mCherry, and GluN1 CRISPR (Supplementary Fig. 9e, f). We
tested whether EphB2 knockdown would result in increased
recovery of WT NMDARs in spine synapses using our
molecular replacement strategy. Knockdown of endogenous
EphB2 with a validated shRNA17,46 signiﬁcantly increased WT
EGFP–GluN1 mobility in dendritic spine synapses (Fig. 8c).
This effect was rescued by expressing shRNA-insensitive
EphB2 (Fig. 8c, d, ****p < 0.0001, KS test; 15 min time point,
*p < 0.05, ANOVA). Consistent with previous studies showing
that EphB2 is required for proper synaptic NMDAR
localization13,19, these data indicate that NMDAR mobility is
regulated by EphB2.
If the loss of the EphB–NMDAR interaction mediates the
increase in mobility of the negatively charged GluN1 NTD
mutants, we expect that knockdown of EphB2 should result in no
further increase in EGFP–GluN1 N273A/R337D mobility in
those neurons. Consistent with this model, knockdown of EphB2
in neurons expressing N273A/R337D EGFP–GluN1 resulted in
no additional increase in recovery (Fig. 8c, d, ****p < 0.0001, KS
test). Together, these data suggest that the positive charge of the
hinge region of the GluN1 NTD is necessary for the EphB-
NMDAR interaction and that this interaction regulates mobility
of NMDARs.
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The EphB–NMDAR interaction is charge-dependent. The
predicted structure of the charged hinge domain indicates that
mutation of R337 results in modiﬁcation of a feature formed by
the arginine side chain (Figs. 5a and 9c). To achieve a dynamically
modiﬁable surface charge, we took advantage of the pKa of the
side chain of histidine (Fig. 9d). The pKa of histidine is 6.0. At a
pH of 7.3, the deprotonated form of histidine is dominant (95%
deprotonated) and the charge of histidine is neutral. At a pH of
5.0, the imidazole group of histidine is protonated (91% proto-
nated) and is positively charged. Substituting histidine at GluN1
hinge region residues should generate a pH-sensitive molecular
switch for the EphB-NMDAR interaction48–50. Because low pH
(<6.0) would also alter the pKa of any exposed histidine residues
in the extracellular domain, and is known to result in
rearrangements of the NMDAR ectodomain51, we generated
three histidine point mutants in the GluN1 hinge region: I272H,
N273H, and R337H. We expect that the WT and I272H mutant
GluN1 should interact at both pH 5 and pH 7.3, controlling for
the effects of rearrangements. If the EphB–NMDAR interaction is
mediated by a positive surface charge in the hinge region, N273H
and R337H mutants should interact with EphB2 at pH 5.0 but not
at the physiological histidine-neutral pH 7.3.
To test whether the charge of the histidine mutants affect the
interaction with EphB2, PLA was performed under two
different pH conditions (pH 5.0 and pH 7.3). HEK293T cells
were transfected with either WT Myc-GluN1 or each of the
GluN1 histidine mutants (I272H, N273H, and R337H), together
with GluN2B, EphB2, and EGFP (Fig. 9a, b). Transfected
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of DIV21–23 cortical neurons transfected with EGFP–GluN1 (WT, I272A, or N273A/R337D) together with GluN2B, CRISPR construct targeting endogenous
GluN1, and mCherry. Recovery of bleached spine puncta (magenta circle) was monitored for 15 min at 10s intervals. Scale bar= 2 µm. b Quantiﬁcation of
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Kolmogorov–Smirnov (KS) nonparametric test). Inset: Quantiﬁcation of the mobile fraction of EGFP–GluN1 spine puncta at 15 min after photobleaching in
EGFP–GluN1 mutant transfected cells compared to WT EGFP–GluN1 in DIV21–23 cortical neurons (*p < 0.05, ANOVA; green dots represent WT n= 33
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HEK293T cells were placed in either pH 5.0 (H-positive) or pH
7.3 (H-neutral) cell culture media for 20 min and then ﬁxed. All
GluN1 mutants expressed and were found at the surface at similar
or higher levels compared to WT GluN1 in HEK293T cells at
both pH 5.0 and pH 7.3 (Supplementary Fig. 10a–c). PLA was
conducted for the extracellular domains of GluN1 (anti-Myc) and
EphB2 (anti-EphB2) without permeabilization. As expected if
positive charge is necessary for the interaction, there were no
signiﬁcant differences in PLA puncta density between conditions
at pH 5.0 (H-positive) (Fig. 9a, b). Moreover, although there may
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be rearrangements of the extracellular domain at low pH that
may disrupt NMDAR channel function51, there were no effects of
pH on PLA puncta density in WT or I272H GluN1-transfected
cells, suggesting that pH does not affect the ability of EphB2 and
the NMDAR to interact (Fig. 9a, b. WT, p= 0.7464; I272H, p=
0.9999; ANOVA). However, in both N273H and R337H mutant
GluN1 conditions at physiological pH (pH 7.3, H-neutral), the
number of PLA puncta was signiﬁcantly reduced compared to
WT or I272H GluN1 (Fig. 9a, b. ***p < 0.0005, ANOVA). These
data suggest that a positive surface potential in the hinge region at
amino acid positions 273 and 337 of the GluN1 NTD is necessary
for the EphB–NMDAR interaction.
Disrupting the EphB2–NMDAR interaction by mutating the
hinge region of GluN1 results in increased mobility of NMDARs
found in dendritic spines. We next asked if we could change the
mobility of GluN1 by dynamically changing the charge of the
hinge region in neurons. Primary cortical neurons were
transfected with either WT, 1272H, or R337H EGFP–GluN1,
and GluN2B, mCherry, and GluN1 CRISPR. Calcium imaging in
live neurons revealed that the histidine point mutation does not
affect channel function at pH 7.3 (Supplementary Fig. 5). Surface
staining showed that both mutant and WT GluN1 receptors were
localized to the neuron surface at both pH 5.0 and pH 7.3
(Supplementary Fig. 10d, e). In addition, the acidity of ACSF at
pH 5.0 quenches the EGFP signal, resulting in less average
ﬂuorescence intensity compared to pH 7.3. These data suggest the
EGFP tag is exposed to the extracellular environment and GluN1
is surface localized (Supplementary Fig. 10d, e and f–i, *p < 0.05,
paired t-test)52.
To dynamically determine the impact of charge of the hinge
region on the mobility of GluN1 in individual cortical neurons,
FRAP was performed on EGFP–GluN1 puncta in dendritic spines
of neurons placed into pH 5.0 or 7.3 ACSF immediately prior to
imaging. Images were acquired every 10 s for 15 min to examine
EGFP–GluN1 recovery. The pH of the ACSF was then changed
and new puncta in the same neuron were selected for FRAP.
Results were the same regardless of the order of pH presentation.
At pH 5.0 (H-positive), recovery was indistinguishable between
WT EGFP–GluN1 and all of the histidine mutants (Fig. 9e–g).
These data suggest that under these conditions, NMDAR channel
function is not required for receptor stabilization at synaptic sites.
Consistent with the importance of charge for the EphB–NMDAR
interaction, at physiological pH (pH 7.3, H-neutral) when
histidine loses its positive charge, EGFP–GluN1 R337H recovered
signiﬁcantly more than both I272H and WT EGFP–GluN1
(Fig. 9e–g, ****p < 0.0001, KS test; 15 min time point, *p < 0.05,
ANOVA). There were no differences between WT and I272H
EGFP–GluN1 at either pH (Fig. 9e–g, dark red and dark blue
curves). These data suggest that the charge of R337, not the side
chain of the arginine is critical for NMDAR mobility. Thus, the
EphB–NMDAR interaction is mediated by a charge-dependent
mechanism and is likely an important regulator of the dynamic
stability of the NMDAR at spines.
Discussion
The mechanisms that regulate the synaptic localization of the
NMDAR have been the subject of intense study. Here, we show
that the EphB–NMDAR interaction is involved in regulating
NMDAR localization to dendritic spine synapses and deﬁne the
structural interface (N273 and R337) of the GluN1 NTD required
for the EphB–NMDAR interaction. EphBs are extracellularly
phosphorylated at Y504 upon activation by ephrin-B, which is
required for the EphB–NMDAR interaction19. Disruption of the
interaction by changing the surface charge of this region increases
NMDAR mobility in dendritic spines. These ﬁndings indicate
that, similarly to other protein–protein intracellular interactions
that are regulated by phosphorylation, the extracellular EphB2-
binding domain on GluN1 likely consists of a positively charged
domain to coordinate with the negative charge of a p*Tyr in the
EphB2 FN3 domain. Given that a number of other synaptic
proteins contain extracellular p*Tyr residues in homologous FN3
domains19, these ﬁndings suggest a conserved general charge-
based mechanism for interaction of the extracellular domains of
synaptic proteins.
Phosphorylation of Y504 in the extracellular domain of EphB2
is necessary and sufﬁcient to induce the EphB–NMDAR inter-
action19. Extracellular kinases that mediate phosphorylation of
extracellular tyrosines have recently been identiﬁed26. However,
how phosphorylation of these sites might mediate interactions
between proteins has not been elucidated. Our data suggest that
similar to intracellular interactions, positively charged domains
appear to be important for recognition and p*Tyr binding.
Interestingly, the positively charged EphB-binding domain on
GluN1 requires an arginine residue perhaps to coordinate the
negative charge of p*Tyr at Y504. Similarly, both SH2 and PTB
intercellular p*Tyr-binding domains contain arginine
residues23,24. However, the structure of the GluN1 hinge region
differs from the deﬁned SH2 and PTB domains, with the GluN1
hinge region containing ﬂexible linker structures rather than
structurally rigid β-sheets. This suggests the GluN1 hinge region
may deﬁne a p*Tyr interacting domain.
All ionotropic glutamate receptors contain an NTD with a
similar structure that appears to be a binding hub for extracellular
protein–protein interactions and allosteric modulators10. Indeed,
ionotropic glutamate AMPA receptors (AMPAR) lacking the
Fig. 9 pH-sensitive histidine mutants in the hinge region elucidate a charge-dependent mechanism. a Representative images of PLA results in
HEK293T cells. HEK293T cells were transfected with the indicated Myc-GluN1 single point mutants, together with GluN2B, FLAG-EphB2, and EGFP. Cells
were treated with media at either pH 5.0 or pH 7.3 for 30min before PLA. Upper panels: PLA signal alone. Lower panels: merge of EGFP in green and PLA
signal in magenta. Scale bar= 10 µm. b Quantiﬁcation of the effects of GluN1 mutants and pH on PLA puncta number (****p < 0.0005, ANOVA; green dots
represent n= 30 cells for each condition). c Surface representation models (top) and charge maps (bottom) of WT GluN1 and R337H GluN1 predicted at
neutral pH. dModel of experimental design. The same neurons were imaged for both pH conditions. e Representative FRAP images at different time points
of DIV21–23 cortical neurons transfected with EGFP–GluN1 (WT or R337H) together with GluN2B, CRISPR construct targeting endogenous GluN1, and
mCherry. FRAP of GluN1 puncta was conducted in the same neurons at pH 5.0 (H-positive) and pH 7.3 (H-neutral) and the order of pH presentation
varied. Recovery of bleached spine puncta (magenta circle) was monitored for 15 min at 10s intervals. Scale bar= 2 µm. f Left: Quantiﬁcation of the
recovery curve of GluN1 WT or R337H mutant in ACSF at pH 7.3 and pH 5.0 in DIV21–23 cortical neurons. Graphs represent mean intensity and show ﬁt
(****p < 0.0001, Kolmogorov–Smirnov (KS) nonparametric test). Right: Quantiﬁcation of the mobile fraction of EGFP–GluN1 spine puncta at 15 min after
photobleaching (*p= 0.0398, WT-pH7.3 vs. R337H-pH7.3; ANOVA; green dots represent WT-pH5.0 n= 26 puncta; R337H-pH5.0 n= 24; WT-pH7.3
n= 23; R337H-pH7.3 n= 35). Error bars show S.E.M. g Left: Quantiﬁcation of the recovery curve of GluN1 WT or I272H mutant in ACSF at pH7.3 and
pH5.0 in DIV21–23 cortical neurons. Graphs represent mean intensity and show ﬁt. (p= 0.8148, WT-pH7.3 vs. I272H-pH7.3, Kolmogorov–Smirnov (KS)
nonparametric test). Right: Quantiﬁcation of the mobile fraction of EGFP–GluN1 spine puncta at 15 min of FRAP (p= 0.9839; WT-pH7.3 vs. I272H-pH7.3;
ANOVA; green dots represent WT-pH5.0 n= 26 puncta; I272H-pH5.0 n= 22; WT-pH7.3 n= 23; I272H-pH7.3 n= 30). Error bars show S.E.M.
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extracellular NTD in the GluA2 subunit exhibit increased
mobility in synapses53. The NTD of other glutamate receptors
seems to mediate extracellular interactions with a number of
proteins, such as N-cadherin54 and neuronal pentraxins (NARP
and NP1) with AMPA receptor subunits55–57 and Cbln1 with
GluRδ258,59. Our study is an example of an endogenous protein
interaction with the hinge region of the GluN1 NTD. Additional
effort will be needed to determine whether charge-based
mechanisms are responsible for other glutamate receptor
interactions.
The extracellular subunits that comprise the NMDAR share
similar structures, including an LBD located near the cell mem-
brane and an NTD. The NTDs of NMDAR subunits can mod-
ulate NMDAR channel function via interaction with allosteric
regulators7. The binding partners of the GluN2 subunits are
much better characterized than those of the GluN1 subunit. The
NTD of the GluN2B subunit of the NMDAR has at least three
distinct binding sites for allosteric regulators, with zinc and
ifenprodil functioning as allosteric inhibitors and polyamines
acting to enhance NMDAR receptor activity9. Interestingly,
spermine, a positive allosteric modulator of GluN2B-containing
NMDARs, binds to the hinge region and lower lobe of the
GluN1–GluN2B NTD interface in a charge-dependent manner8,9.
NMDARs move into and out of synaptic sites16. Single particle
tracking and FRAP show that there are barriers to the lateral
diffusion of NMDARs that help to maintain the position of the
receptors within the postsynaptic density (PSD)11,60–62. Our data
support a model in which the EphB–NMDAR interaction reg-
ulates NMDAR mobility and helps to anchor NMDARs at
synaptic sites. Anchoring of the NMDAR appears to be important
for maintaining spine density. Blocking the EphB–NMDAR
interaction results in a reduction in spine density that is depen-
dent on expression of EphB2, suggesting that EphB2 may act as a
punishment signal in the absence of an interaction with GluN1,
driving a loss of spines. Regardless, EphB2, which is found in the
core of the PSD63, provides a potential hub for protein–protein
interactions to selectively maintain the NMDAR in the core of the
PSD and, through the transsynaptic EphB2–ephrin-B interaction,
localized adjacent to presynaptic release sites. This mechanism of
NMDAR stabilization may reveal new avenues of research
towards understanding pathological conditions involving dys-
function of the NMDARs at the synapse and extracellular
protein–protein interactions19,20.
Methods
Animals. All animal procedures were approved by the Institutional Animal Care
and Use Committee of Thomas Jefferson University (01286 and 01289). Long
Evans rats (Charles River) were used for preparing dissociated cortical neuron
cultures as described below17,46. CD-1 mice (Charles River) were used for pre-
paring synaptosomes.
Synaptosomes. Synaptosomes were prepared from postnatal day 21 (P21) wild-
type CD-1 mice31. Brains were homogenized on ice in 0.32M sucrose, 4 mM
HEPES, pH 7.4, containing a protease inhibitor cocktail (Sigma) and 1 mM PMSF.
After removing the nuclear fraction by centrifugation at 1000×g for 15 min at 4 °C,
non-synaptic fractions were further centrifuged at 10,000×g at 4 °C to obtain the
crude synaptosomal fraction. Puriﬁed synaptosomes were obtained by centrifuga-
tion of this fraction through a gradient of 1.2 M sucrose to 0.8 M sucrose. To plate
frozen synaptosomes,64 coverslips were prepared as follows. Using a PEI Stock
Solution (1:15 Stock: 3.3 mL 50% (wt/vol) PEI in 46.7 mL dH2O), 50 mL 1:15,000
PEI dilution was prepared (50 μL stock in 50 mL dH2O). 400 μL PEI dilution was
added to glass coverslips in a 24-well plate to incubate at 37 °C overnight (or up
to 48 h). PEI was removed from coverslips and coverslips were allowed to dry at
37 °C for 30 min. Dried coverslips were kept at 4 °C while preparing synaptosomes.
Frozen synaptosomes were thawed on ice and diluted to 20 ng/mL in SET buffer
(0.32 M Sucrose, 1 mM EDTA, 5 mM Tris, pH 7.4) with 250 μM DTT. Diluted
synaptosomes were pipetted onto prepared cover slips at a concentration of 8 μg
per cover slip. Cover slips were centrifugated in a 24-well plate at 1500×g for
30 min at 4 °C and then immunostained.
Expression constructs. EGFP–GluN1 was purchased from Addgene (Watertown,
MA; ID 45446). For neuronal transfection, the EGFP–GluN1 fragment was cloned
into a synapsin promoter-containing pLV-hSyn vector to ensure its expression only
in neurons. Single point mutations were introduced using sequence-speciﬁc pri-
mers (see Primers in Supplement) and site-directed mutagenesis. For HEK293T
PLA experiments, the GluN1 EGFP tag was switched to a Myc tag using sequence-
speciﬁc primers. FLAG-tagged EphB2 and HA-tagged GluN2B were generated and
used previously13.
HEK293T cell culture and transfection. HEK293T cells (Greenberg lab, originally
from ATCC) were maintained in DMEM (Invitrogen), 10% fetal bovine serum
(Atlanta Biologicals), 1% penicillin–streptomycin (Invitrogen), and 1% glutamine
(Invitrogen). Cells were transfected with Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol or with calcium phosphate65. Brieﬂy, the
pH of 2X HeBS (274 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4·7H2O, 15 mM D-
glucose, 42 mM HEPES) was adjusted by NaOH to yield pHs ranging from 7.03,
7.05, 7.07, 7.09, 7.11, to 7.14. 2X HeBS was ﬁlter-sterilized, aliquoted and stored at
4 °C. Each pH was tested to determine which provided the best transfection efﬁ-
ciency. To prepare transfection mixture, 70 µL of HEPES-buffered dH2O (2.5 mM
HEPES) was added to an Eppendorf tube, 8.65 µL of 2.5 M CaCl2 was added to the
bottom of the HEPES-containing tube, then plasmid DNA was added on top of the
CaCl2–HEPES mixture and mixed by adding 86.5 µL of the most pH effective 2X
HeBS. Precipitation was initiated by bubbling the transfection mixture with a
pipette 8–10 times. The mixture was immediately added to HEK cells (one
transfection mixture per one well of a six-well plate) dropwise. Transfected cells
were immunostained, imaged or lysed 16–24 h after transfection. Myc-GluN1,
GluN2B, FLAG-EphB2, and EGFP constructs were co-transfected for HEK293T
PLA experiments. 50 µM APV (Tocris Bioscience) and 10 µM MK801 (Tocris
Bioscience) were added after transfection to prevent excitotoxicity.
Primary neuronal culture. Rat cortical cultures were prepared from embryonic
day 17 (E17) rat embryos17,46. Embryos were harvested and brains were isolated in
ice-cold 20 mM HEPES-buffered Hank’s balanced salt solution (HBSS). Meninges
were removed using ﬁne forceps. The striatum and hippocampi were separated and
discarded and cortices were collected. Cortices were incubated with 10 µg/mL
papain (Worthington Biochemical Corporation) in HBSS for 4 min at 37 °C. After
three washes in HBSS with 0.01 g/mL trypsin inhibitor (Sigma), the cortices were
gently triturated with a ﬁre-polished glass Pasteur pipette 5–10 times to obtain a
homogeneous cell suspension. Bubbling was avoided and the pipette was main-
tained within the cell suspension during the trituration. Neurons were plated on
poly-D-lysine (BD Biosciences, Bedford, MA) and laminin (BD Biosciences)-coated
glass coverslips (12 mm; Bellco Glass, Vineland, NJ) in 24-well plates (Corning Life
Sciences, Lowell, MA). For FRAP experiments, neurons were plated on glass
bottom dishes (35 mm, GBD00002-200, Cell E&G). Standard density for neuronal
cultures was 6 × 105 cells/cm2. Neurons were cultured in Neurobasal media
(Invitrogen, Carlsbad, CA) supplemented with B-27 (Invitrogen), 1% glutamine
(Invitrogen), and 1% penicillin–streptomycin (Invitrogen). Neurons were trans-
fected using Lipofectamine 2000 (Invitrogen, see below)17,46. For neurons trans-
fected with NMDARs, 100 µM APV was added every 2 days after transfection.
Neuronal transfection. Neurons were transfected either at day in vitro 0 (DIV0) in
suspension17,46 or DIV3 using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and
processed for ICC or transfected at DIV14 using Lipofectamine 2000 (Invitrogen)
and processed for FRAP at DIV21-23. Transfection mixture was prepared (per
coverslip) as follows: 0.5 µL Lipofectamine 2000 was added to 50 µL neurobasal
medium (without supplement) in a polystyrene tube (USA Scientiﬁc). DNA was
added to 50 µL neurobasal medium (without supplement) in an Eppendorf tube.
After 5 min, the DNA mixture was slowly added to Lipofectamine mixture drop-
wise. The combined mixture was mixed by bubbling two times and incubated at
room temperature for 15 min. While the transfection mixture incubated, the
conditioned media was removed from the neuronal cultures, saved at 37 °C, and
replaced with 300 µL of warm neurobasal medium (without supplement) per one
well of a 24-well plate and kept at 37 °C until ready for transfection. The trans-
fection mixture was added dropwise to the neuronal culture and incubated for 2 h
at 37 °C. Then transfection media was replaced with ﬁlter-sterilized warm condi-
tioned media and the neuronal culture was returned to the incubator. For RCaMP
experiments, Synapsin–EGFP–GluN1 was co-transfected with RCaMP (pAAV.Syn.
NES-jRCaMP1b.WPRE.SV40)44, pFUG–HA–GluN2B, and GluN1 CRISPR con-
structs. For all other experiments, Synapsin–EGFP–GluN1 was co-transfected with
pFUG–HA–GluN2B, CAG–mCherry, and GluN1 CRISPR constructs. GluN1
CRISPR (pX330-U6-Chimeric_BB-CBh-hSpCas9) was obtained from Addgene
and transfected as described above and is a published construct42,43. GluN2B was
chosen to be co-expressed with GluN1 because GluN2B is expressed in young
neurons, the synaptic incorporation of GluN2B-containing receptors is not limited
by synaptic transmission nor enhanced by increased subunit expression, and
GluN2 subunit expression promotes NMDAR surface localization of exogenously
expressed receptors66.
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Proximity ligation assay. PLA experiments were performed using the Duolink In
Situ Orange Detection Kit (DUO 92105, Sigma) based on manufacturer’s protocol.
For pH-speciﬁc experiments, HEK293T cells were treated with media at either pH
5.0 or pH 7.3 for 30 min before ﬁxation. PLA images were collected using a Leica
TCS SP8 confocal with a ×63 objective lens. Pictures shown were Z stacks of
whole cells.
Immunoprecipitation. Immunoprecipitations were performed on ice13,19. Trans-
fected HEK293T cells were lysed in 350 µL (per well for six-well plates) RIPA buffer
(20 mM Tris–Cl pH 7.5, 140 mM NaCl, 2 mM EDTA, 10 mM NaF (Sigma), 1%
NP40 (Thermo Scientiﬁc), 0.5% sodium deoxycholate, 1 mM Na3VO4, 1 mM
PMSF, and protease inhibitor cocktail (all from Sigma)). Cell lysates were harvested
and centrifuged at 16,000×g for 25 min at 4 °C to pellet cellular debris. A fraction of
the resulting supernatant (50 µL per well for 6-well plates) was removed as an input
control. The remaining supernatant was incubated with rabbit polyclonal anti-
FLAG to conjugate on ice for 1.5 h. Antibody-bound proteins were then isolated
using protein-G agarose beads (Invitrogen) pre-blocked with BSA on a rotator at
4 °C for 1 h. Samples were then centrifuged and beads were washed three times in
RIPA lysis buffer and two times in TBS-V. Immunoprecipitants were eluted from
the agarose beads by adding boiling SDS-sample buffer containing 32% 2-
Mercaptoethanol (Sigma) and 9% 1,4-Dithiothreitol (DTT, Sigma) and boiled at
70 °C for 10 min.
Western blotting. Lysates from HEK293T cells were separated by
SDS–polyacrylamide gel electrophoresis (SDS–PAGE) using 8% Tris–glycine gels
and transferred onto 0.45 µm PVDF membranes (Millipore). Immunoblots were
then blocked in 5% nonfat dry milk in TBS-T (150 mM NaCl, 10 mM Tris pH 8.0,
0.05% Tween-20). Blots were incubated with primary antibodies in blocking
solution for 2 h at room temperature or overnight at 4 °C. HRP-conjugated sec-
ondary antibodies were used at 1:10,000 in blocking solution for 1 h at room
temperature then visualized using ECL (PerkinElmer, Waltham, MA) and auto-
radiography ﬁlm (HyBlot Film, Denville Scientiﬁc).
Immunocytochemistry. For GluN1 surface staining, live neurons were stained for
10 min at 37 °C in artiﬁcial cerebrospinal ﬂuid (ACSF, 140 mM NaCl, 5 mM KCl,
1 mM MgCl2, 2 mM CaCl2, 20 mM glucose, and 10 mM HEPES, pH 7.3)67 with
anti-EGFP, then washed with ACSF once and ﬁxed with 4% paraformaldehyde/2%
sucrose in PBS. For live-cell surface staining in the pH-speciﬁc experiments,
neurons were treated with media at either pH 5.0 or pH 7.3 for 30 min and then
live cell-stained for 10 min with anti-EGFP in their respective pH-adjusted med-
ias at 37 °C . After several washes, cells were ﬁxed with 4% paraformaldehyde/2%
sucrose and blocked with PBS containing 1% ovalbumin (Sigma) and 0.2% cold
water ﬁsh skin gelatin (Sigma). After blocking, cells were incubated with secondary
antibodies in the previously described blocking reagent for 45–60 min at room
temperature. Cells were then washed three times in PBS before mounting on glass
microscope slides (Fisher) with Aqua-Mount (Lerner, Kalamazoo, MI). For
detection of EphB2 and EGFP–GluN1 via confocal microscopy, neurons were ﬁxed
with 4% paraformaldehyde/2% sucrose at room temperature. After several washes,
cells were blocked with PBS containing 1% ovalbumin and 0.2% cold water ﬁsh
skin gelatin (Sigma) for 45 min at room temperature, then incubated with primary
antibody for 2 h at room temperature in the previously described blocking reagent.
For staining of Myc-GluN1 and FLAG-EphB2 in HEK293T cells, cells were ﬁxed in
the same way as neurons. For pH-speciﬁc experiments, HEK293T cells were
treated with media at either pH 5.0 or pH 7.3 for 30 min before ﬁxation. Following
ﬁxation with 4% paraformaldehyde/2% sucrose in PBS, cells were blocked and
permeablized with PBS containing 1% ovalbumin, 0.2% cold water ﬁsh skin gelatin,
and 0.01% saponin for 45 min at room temperature, then immunostained with
primary antibodies in blocking reagent for 1 h at room temperature. After washing
three times with PBS, cells were incubated with secondary antibodies in blocking
reagent for 45–60 min at room temperature. Cells were then washed three times in
PBS before mounting on glass microscope slides (Fisher) using Aqua-Mount
(Lerner, Kalamazoo, MI).
Calcium imaging. Experiments were conducted with a Leica TCS SP8 confocal
scanning microscope. Cultured neurons on coverslips were removed from the
culture dish, placed in an imaging perfusion chamber with low calcium (1 mM), no
magnesium ACSF and imaged using a ×63 oil immersion lens (Leica). Cells co-
transfected with EGFP–GluN1 and RCaMP (pAAV.Syn.NES-jRCaMP1b.WPRE.
SV40)44 were imaged for 600 frames (2 min) at 5 frames per second. Low calcium,
no magnesium ACSF containing 25 µM CNQX (Tocris, IL), 40 µM Nifedi-
pine (Tocris, IL), and 1 µM Tetrodotoxin (Cayman, MI; ACSF*) was perfused onto
the cells for 100 frames (20 s). After 100 frames, ASCF* was switched off and
ASCF* plus 10 µM glutamate and 50 µM glycine was switched on for 50 frames
(10 s). Glutamate was turned off and ACSF* was then switched back on for the
remaining 450 frames (90 s). Each cell was imaged three times and response was
averaged. ACSF* containing 100 µM APV (Tocris, IL) was then perfused on and
the imaging process described above was repeated in the presence of APV to ensure
cell response was NMDAR-speciﬁc.
Fluorescence recovery after photobleaching (FRAP). Experiments were con-
ducted with a Leica TCS SP5 or SP8 confocal scanning microscope. Cultured
neurons on coverslips were removed from the culture dish, placed in an imaging
chamber with ACSF and imaged using a ×63 oil immersion lens (Leica). Photo-
bleaching of GluN1–EGFP puncta in mushroom-shaped spines (or on dendritic
shaft as indicated) was performed by the Leica bleach points algorithm associated
with a Leica TCS SP5/SP8 confocal microscope using 100 ms of a 488 nm laser set
at 20% power. For pH-speciﬁc FRAP experiments, neurons were grown in round
glass bottom dishes (Cell E&G). pH-speciﬁc ACSF was removed and replaced with
a pipette while the dish of neurons remained stationary between conditions.
Imaging began within 5 min or less of media replacement. Cells were randomly
imaged with either pH 7.3 ﬁrst or pH 5.0 ﬁrst. A different GluN1 puncta was
imaged on the same cell after pH switch for paired comparisons. The ﬁrst image of
each of these experiments (before bleaching) was used to measure ﬂuorescence
intensity for pH quenching results.
FRAP analysis. EGFP intensity of bleached puncta and three randomly selected
unbleached puncta were quantiﬁed for each time point by selecting the regions of
interest (ROIs) around selected puncta in every image in the time series45. The
unbleached puncta served as a control for the photobleaching during acquisition.
The recovery of bleached EGFP puncta was normalized to the average intensity of
these control puncta at each time point. The recovery of bleached puncta (repre-
sented as EGFP intensity) was then determined using the equation: ((Ft−F0)/
(Fpre−F0)), where Ft is the EGFP ﬂuorescence measured at different time intervals,
F0 is the EGFP ﬂuorescence immediately after photobleaching at t= 0 s, and Fpre is
the average EGFP ﬂuorescence intensity before photobleaching. These values were
then divided by (CtrlFt/CtrlFpre), where CtrlFt is the EGFP ﬂuorescence of control
unbleached puncta measured at different time intervals and CtrlFpre is the average
EGFP ﬂuorescence intensity of the ﬁrst ﬁve frames of control unbleached puncta,
to control for slight variations in focus.
Antibodies. The following primary antibodies and dilutions were used: mouse
monoclonal (IgG1) anti-GluN1 (1:500 (WB), BioLegend, clone R1JHL, cat#
828201, lot# B212895), goat polyclonal anti-EphB2 (1:1200 (ICC, PLA), R&D
Systems, cat# AF467, lot# CVT0315041), mouse monoclonal (IgG1) anti-EphB2
(1:500 (WB), Invitrogen, clone 1A6C9, cat# 37-1700, lot# RD215698), rabbit
polyclonal anti-Myc (1:3000 (ICC, PLA), Abcam, Cambridge, MA, cat# ab9103,
lot# 2932489), mouse monoclonal (IgG2b) anti-GluN2B (1:500 (WB), Neuromab,
UC Davis, Davis, CA, clone N59/36, cat# 75-101, lot# 455-10JD-82), mouse
monoclonal (IgG2A) anti-PSD-95 (1:2500 (WB), Neuromab, UC Davis, Davis, CA,
clone 28/43, cat# 75-028, lot# 455.7JD.22f), mouse monoclonal (IgG1) anti-
Synaptophysin-1 (1:5000 (WB), Synaptic Systems, Gottingen, Germany, clone 7.2,
cat# 101 111, lot# 101011/1-43), guinea pig polyclonal anti-vesicular glutamate
transporter 1 (vGlut1; 1:5000 (WB, ICC), EMD Millipore, Temecula, CA, cat#
AB5905, lot# 2932489), rabbit polyclonal anti-GFP (1:3000 (ICC), Life Technolo-
gies, cat# A6455, lot# 1736965), mouse monoclonal (IgG1) anti-GAPDH (1:500
(WB), EMD Millipore, Temecula, CA, cat# MAB374, lot# 2910381), rabbit poly-
clonal anti-Tubulin (1:10,000 (WB), Abcam, Cambridge, MA, cat# ab18251, lot#
GR235480-2), rabbit polyclonal anti-actin (1:2000 (ICC), Sigma, cat# A2103, lot#
115M4865V), rabbit polyclonal anti-FLAG (1:1000 (IP, WB), Sigma, Cat# F7425,
lot# 097M4882V). The following secondary antibodies were used: Donkey anti-
mouse-HRP (1:10,000 (WB), Jackson ImmunoResearch, cat# 715-035-151, lot#
128396), Donkey anti-rabbit-HRP (1:10,000 (WB), Jackson ImmunoResearch, cat#
711-035-152, lot# 132960), Donkey anti-goat-HRP (1:10,000 (WB), Jackson
ImmunoResearch, cat# 705-035-147, lot# 112876), Donkey anti-rabbit unconju-
gated (1:100 (ICC), Jackson ImmunoResearch, cat# 711-005-152 lot# 125861),
Donkey anti-mouse AlexaFluor-488 (1:500 (ICC), Jackson ImmunoResearch, cat#
715-545-150, lot# 11603), Donkey anti-rabbit AlexaFluor-488 (1:500 (ICC), Jack-
son ImmunoResearch, cat# 711-545-152, lot# 126601), Donkey anti-goat Cy3
(1:500 (ICC), Jackson ImmunoResearch, cat# 705-166-147, lot# 107019), Donkey
anti-rabbit Cy3 (1:500 (ICC), Jackson ImmunoResearch, cat# 711-165-152, lot#
123091), Donkey anti-guinea pig AlexaFluor-647 (1:500 (ICC), Jackson Immu-
noResearch, cat# 706-605-148, lot# 116734), Donkey anti-goat AlexaFluor-647
(1:500 (ICC), Jackson ImmunoResearch, cat# 706-606-147, lot# 124186).
Statistical analysis. Data are expressed as means with individual values overlaid
as dots. Error bars represent standard error of the mean (S.E.M.). Statistical sig-
niﬁcance of differences among groups was determined by one-way analysis of
variance (ANOVA) followed by Tukey’s post-hoc test or t-tests as noted in the
ﬁgure legends. FRAP curves were compared using KS nonparametric test. Dis-
tribution of data was assumed to be normal, but this was not formally tested.
Probability values of <5% were considered statistically signiﬁcant with * repre-
senting p < 0.05, ** representing p < 0.01, *** representing p < 0.005, and ****
representing p < 0.001 unless otherwise indicated. Data were collected from a
minimum of three independent experiments.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
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Data availability
Data supporting the ﬁndings of this manuscript are available from the corresponding
author upon reasonable request. A reporting summary for this article is available as a
Supplementary Information ﬁle. The source data underlying Figs. 1b, d, 2h, 3b–d, 4b, 5c,
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